By the in vitro experiment, we found that blocking of MUC4 and MUC20 could contribute to the increase in the sensitivity of ESCC cell lines to paclitaxel, whereas blocking of MUC13 resulted in a decrease in the sensitivity of ESCC cell lines to paclitaxel. The gene discussed is MUC4; the disease is esophageal squamous cell carcinoma.